These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 2183724

  • 21. The economics of end-stage renal disease care in Canada: incentives and impact on delivery of care.
    Manns BJ, Mendelssohn DC, Taub KJ.
    Int J Health Care Finance Econ; 2007 Sep; 7(2-3):149-69. PubMed ID: 17641968
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Special treatment--the story of Medicare's ESRD entitlement.
    Rettig RA.
    N Engl J Med; 2011 Feb 17; 364(7):596-8. PubMed ID: 21323539
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Pediatric ESRD patients & their special treatment challenges.
    Cole BE.
    Nephrol News Issues; 1989 Aug 17; 3(8):30-2. PubMed ID: 2674728
    [No Abstract] [Full Text] [Related]

  • 28. Financing of end-stage renal disease care: past, present, and future.
    Farley DO.
    Adv Ren Replace Ther; 1994 Apr 17; 1(1):24-31. PubMed ID: 7641085
    [Abstract] [Full Text] [Related]

  • 29. Renal Dialysis and its Financing.
    Borelli M, Paul DP, Skiba M.
    Hosp Top; 2016 Apr 17; 94(2):33-8. PubMed ID: 27315562
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Medicare program; end-stage renal disease quality incentive program. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS.
    Fed Regist; 2011 Jan 05; 76(3):627-46. PubMed ID: 21261127
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. ESRD special needs plans: a proof of concept for integrated care.
    Krishnan M, Franco E, McMurray S, Petra E, Nissenson AR.
    Nephrol News Issues; 2014 Nov 05; 28(12):30, 32, 34-6. PubMed ID: 26012119
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Reimbursement and ESRD. The future of managed care and the ESRD program.
    Latos D, White M.
    Nephrol News Issues; 1995 Jul 05; 9(7):11. PubMed ID: 7566196
    [No Abstract] [Full Text] [Related]

  • 37. The American health care system. The End Stage Renal Disease Program.
    Iglehart JK.
    N Engl J Med; 1993 Feb 04; 328(5):366-71. PubMed ID: 8419833
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Evaluating the Evidence behind Policy Mandates in US Dialysis Care.
    Erickson KF, Winkelmayer WC.
    J Am Soc Nephrol; 2018 Dec 04; 29(12):2777-2779. PubMed ID: 30389727
    [No Abstract] [Full Text] [Related]

  • 40. American Society of Pediatric Nephrology position paper on linking reimbursement to quality of care.
    Andreoli SP, Brewer ED, Watkins S, Fivush B, Powe N, Shevchek J, Foreman J.
    J Am Soc Nephrol; 2005 Aug 04; 16(8):2263-9. PubMed ID: 15987749
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.